首页> 外文OA文献 >SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE : INCIDENCE OF SENSITIVITY AMONG LEUKEMIAS OF VARIOUS TYPES: COMPARATIVE INHIBITORY ACTIVITIES OF GUINEA PIG SERUML-ASPARAGINASE AND ESCHERICHIA COLI L-ASPARAGINASE
【2h】

SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE : INCIDENCE OF SENSITIVITY AMONG LEUKEMIAS OF VARIOUS TYPES: COMPARATIVE INHIBITORY ACTIVITIES OF GUINEA PIG SERUML-ASPARAGINASE AND ESCHERICHIA COLI L-ASPARAGINASE

机译:L-天冬酰胺酶对小鼠白血病的抑制作用:各种类型白血病之间的敏感性发生:几内亚猪精氨酸-天冬酰胺酶和大肠杆菌C-L-天冬酰胺酶的比较抑制活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A survey of 109 recently derived leukemias of the mouse revealed that sensitivity to suppression by guinea pig serum is a common property of transplanted leukemias of certain classes. The sensitive leukemias included five that arose spontaneously in mice of strains with a low incidence of leukemia and 21 that were induced by X-radiation. Two GPS-sensitive leukemias were not more sensitive than a GPS-resistant leukemia to a range of standard chemotherapeutic agents. The effectiveness of L-asparaginase EC-2 from Escherichia coli in suppression of the GPS-sensitive leukemia EARAD1 depends upon the conditions of assay. Whereas it is not inhibitory when administered as a single dose at the time of inoculation of the leukemia it is considerably more effective than GPS when used in the treatment of established leukemia. Permanent cures of 7-day generalized transplants of EARAD1 can be effected by the administration of 2000 or more units of EC-2. Immunological factors apparently do not contribute to cure as treated survivors are fully susceptible to rechallenge with minimal numbers of cells from the same leukemia. Reinoculated survivors with progressively growing transplants have been successfully retreated with EC-2. The blood clearance of EC-2 L-asparaginase injected into mice is much more rapid than that of GPS L-asparaginase. After intraperitoneal inoculation of the EC-1 L-asparaginase, which does not have leukemia-inhibitory activity, only very low levels of enzyme activity could be detected in the serum. The effectiveness of EC-2 from E. coli and its availability from a virtually limitless source will make it possible to extend the study of inhibition of leukemias and other tumors by L-asparaginase to species other than small rodents.
机译:对109个最近衍生的小鼠白血病的调查显示,对豚鼠血清抑制的敏感性是某些类别的移植性白血病的共同特征。敏感性白血病包括五种在白血病发病率低的菌株中自发产生的疾病,以及21种由X射线诱导的疾病。两种对GPS敏感的白血病对一系列标准化疗药物的敏感性不比对GPS耐药的白血病敏感。来自大肠杆菌的L-天冬酰胺酶EC-2抑制GPS敏感白血病EARAD1的有效性取决于测定条件。尽管在接种白血病时以单剂量给药时没有抑制作用,但是当用于治疗已确诊的白血病时,它比GPS更为有效。可以通过施用2000个或更多单位的EC-2来永久治愈EARAD1的7天广义移植。免疫因素显然无助于治愈,因为经过治疗的幸存者完全容易受到来自同一白血病的最少细胞攻击的挑战。具有逐渐生长的移植物的重新接种的幸存者已成功用EC-2治疗。注入小鼠的EC-2 L-天冬酰胺酶的血液清除速度比GPS L-天冬酰胺酶的血液清除速度快得多。腹膜内接种没有白血病抑制活性的EC-1 L-天冬酰胺酶后,血清中只能检测到极低水平的酶活性。来自大肠杆菌的EC-2的有效性及其从几乎无限的来源获得的可用性将使将L-天冬酰胺酶对白血病和其他肿瘤的抑制研究扩展到除小型啮齿类动物之外的其他物种成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号